[MORPHAZINAMIDE IN ANTUBERCULAR THERAPY].
D000818:Animals; D000995:Antitubercular Agents; D004351:Drug Resistance; D004352:Drug Resistance, Microbial; D051379:Mice; D009169:Mycobacterium tuberculosis; D010600:Pharmacology; D011718:Pyrazinamide; D011719:Pyrazines; D014116:Toxicology; D014376:Tuberculosis; D014397:Tuberculosis, Pulmonary
D000995:Antitubercular Agents; D011719:Pyrazines; D011718:Pyrazinamide; C038993:morphazinamide
ANTITUBERCULAR AGENTS; DRUG RESISTANCE, MICROBIAL; MICE; MYCOBACTERIUM TUBERCULOSIS; PHARMACOLOGY; PYRAZINAMIDE; TOXICOLOGIC REPORT; TUBERCULOSIS, PULMONARY
LE MORPHAZINAMIDE EN THERAPEUTIQUE ANTITUBERCULEUSE.